Abbott acquires Cephea Valve Technologies, developer of a minimally invasive mitral valve replacement device

Abbott exercised its option to acquire Cephea Valve Technologies, a private medical device company developing a minimally invasive heart valve replacement for mitral valve disease. Financial terms were not disclosed; the announcement is dated 16 January 2019.

“Abbott ha annunciato di aver esercitato la sua opzione per l’acquisto di Cephea Valve Technologies, un’azienda privata di dispositivi medici.”tecnomedicina.it

• 1 source
• tecnomedicina.itAbbott acquisisce Cephea Valve Technologies - TecnoMedicinaJan 16, 2019

Summarized from public sources; check the original articles before acting on it.